CIM
BDRX

Contravisory Investment Management’s Biodexa Pharmaceuticals BDRX Stock Holding History

Contravisory Investment Management’s Portfolio BDRX Stock Details BDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$53 – 376
2025
Q1 		$53 Hold
4
– – ﹤0.01% 372
2024
Q4 		$162 Hold
4
– – ﹤0.01% 389
2024
Q3 		$282 Hold
4
– – ﹤0.01% 342
2024
Q2 		$896 Buy
+4
New +$896 ﹤0.01% 342